On Invalid Date, Kintara Therapeutics (NASDAQ: KTRA) reported Q1 2024 earnings per share (EPS) of -$0.05, up 97.42% year over year. Total Kintara Therapeutics earnings for the quarter were -$2.01 million. In the same quarter last year, Kintara Therapeutics's earnings per share (EPS) was -$1.94.
As of Q2 2024, Kintara Therapeutics's earnings has grown year over year. Kintara Therapeutics's earnings in the past year totalled -$9.51 million.
What was KTRA's revenue last quarter?
On Invalid Date, Kintara Therapeutics (NASDAQ: KTRA) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Kintara Therapeutics's revenue was $0.00.
What was KTRA's revenue growth in the past year?
As of Q2 2024, Kintara Therapeutics's revenue has grown null year over year. Kintara Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.